Alvotech (NASDAQ:ALVOW – Get Free Report) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 1,032 shares, a decline of 88.7% from the April 15th total of 9,151 shares. Based on an average daily volume of 2,140 shares, the days-to-cover ratio is currently 0.5 days.
Alvotech Price Performance
Shares of NASDAQ ALVOW traded down $0.01 during mid-day trading on Tuesday, hitting $0.25. 2,165 shares of the company were exchanged, compared to its average volume of 4,307. The stock has a 50 day simple moving average of $0.29 and a 200-day simple moving average of $0.56. Alvotech has a 1-year low of $0.15 and a 1-year high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
See Also
- Five stocks we like better than Alvotech
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
